A mutant plasmid vector and its preparation method and application

By constructing a mutant plasmid vector containing ToBRFV gene fragments, combining RNA1 and RNA3 of cucumber mosaic virus RNA2 and CMVFny isolates, an attenuated vaccine against ToBRFV is formed, solving the problem of the lack of effective prevention and treatment of tomato brown wrinkle fruit virus in the prior art. , achieving effective prevention and cross-protection effects on ToBRFV.

CN118374543BActive Publication Date: 2024-11-12QINGDAO AGRI UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410804832.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-06-21
Publication Date
2024-11-12
Estimated Expiration
2044-06-21

AI Technical Summary

Technical Problem

The prior art lacks effective methods to prevent and treat tomato brown wrinkle fruit virus, especially cucumber mosaic virus, as an attenuated vaccine for disease-resistant varieties, but has not been reported.

Method used

By constructing a mutant plasmid vector containing mutant RNA2 of cucumber mosaic virus RNA2 and RNA1 and RNA3 of CMVFny isolate, inserting ToBRFV gene fragments to form an attenuated vaccine against ToBRFV, and transforming it into Agrobacterium to prevent tomato brown wrinkles Infection by viruses.

Benefits of technology

This method provides effective vaccine materials and prevention measures, which can prevent ToBRFV from virulent infestation, significantly reduce the amount of virus replication, and protect the plants from virus hazards.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118374543B_ABST
    Figure CN118374543B_ABST
Patent Text Reader

Abstract

The present invention relates to a mutant plasmid vector and a preparation method and application thereof, and in particular to a mutant plasmid vector for preventing and controlling tomato brown wrinkled fruit virus; the mutant plasmid vector comprises a nucleotide sequence as shown in SEQ ID NO.1 and is named pCB F R2‑2bPT‑ToBRFV 73‑294 The present invention obtains a mutant plasmid vector pCB containing cucumber mosaic virus (CMV) RNA2 F R2‑2bPT‑ToBRFV 73‑294 , and containing CMV Fny The mixed inoculation of the plasmids of the isolate wild-type RNA1 and wild-type RNA3 can prevent the infection of the strong toxin ToBRFV, and can be used as a attenuated vaccine against tomato brown wrinkled fruit virus, and has a preventive effect on ToBRFV.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of plant virology and molecular biology, and in particular to a mutant plasmid vector and a preparation method and application thereof, and in particular to a mutant plasmid vector for preventing and controlling tomato brown wrinkled fruit virus. Background Art

[0002] Viral diseases are the second largest category of plant diseases after fungal diseases, causing varying degrees of damage to most crops. The prevention and control of plant viral diseases is a hot topic and a difficult issue in research. Cucumber mosaic virus (CMV) is one of the plant viruses with the widest host range known to date. It can infect more than 1,222 plants in more than 100 families, causing symptoms such as yellowing, dwarfing, and deformity in a variety of economically important plants (crops, horticultural crops, etc.), seriously affecting their yield and quality (Mochizuki et al., 2012). Tomato brown wrinkled fruit virus (ToBRFV) belongs to the family Baculoviridae ( Virgavirudea ) Tobacco mosaic virus genus ( Tobamovirus ). ToBRFV was first identified and reported by Jordanian scientists in 2015 (Salem et al., 2016). Since then, the virus has spread rapidly around the world and has been detected in more than 30 countries or regions. ToBRFV was first discovered and reported in Yucheng, Shandong in 2019 (Yan et al., 2019). ToBRFV was found to mainly infect tomatoes ( Solanum lycopersicon )(Luria et al., 2017). After the plants are infected, the young leaves and terminal buds show mosaic symptoms such as mottle, spot and yellowing, and the leaves become narrower and deformed; the number of flowers and fruits is greatly reduced, and the petioles, pedicels and calyx gradually necrotize; the fruits are deformed, with yellow, brown or green spots, patches or stripes, and in severe cases, they become deformed, browned and necrotic (Salem et al., 2016; Salem et al., 2020). In severe cases, the economic losses can be as high as 100% (Salem et al., 2016). In view of the potential hazards and impacts of ToBRFV, in April 2021, ToBRFV was included in the "List of Quarantine Pests for Plants Entering the People's Republic of China".

[0003] The most effective method for the prevention and control of plant viral diseases is the screening and breeding of disease-resistant varieties, but it has shortcomings such as long breeding cycles and easy loss of resistance of disease-resistant varieties. Another method is attenuated cross-protection, which is an effective virus prevention and control strategy to use attenuated mutants to infect and induce the plant's own immune system to prevent and control the same type of strong virus strains that infect later. Attenuated mutants can be naturally occurring or artificially prepared by molecular biological methods. The construction of an attenuated vaccine is achieved by inserting a heterologous virus fragment into a backbone virus to achieve the effect of preventing and controlling the virus corresponding to the inserted fragment. This mutant virus is an attenuated vaccine.

[0004] There are currently no reports of vaccines that use cucumber mosaic virus as a basic viral vector and are able to protect against tomato brown wrinkled fruit virus. Summary of the invention

[0005] In view of the above problems, the present invention provides a mutant plasmid vector and a preparation method and application thereof, and specifically relates to a mutant plasmid vector for preventing and controlling tomato brown wrinkle fruit virus. The present invention obtains a mutant plasmid containing cucumber mosaic virus (CMV) RNA2, and combines it with a CMV-containing Fny RNA1 and RNA3 of the isolates were mixed and inoculated to prevent and control tomato brown rugose fruit virus (ToBRFV). Based on this, the mutant plasmid vector obtained in the present invention was mixed with a plasmid containing CMV Fny The mixture of RNA1 and RNA3 of the isolates constitutes an attenuated vaccine against ToBRFV, which provides vaccine materials and effective prevention and control measures for field prevention and control of plant virus diseases caused by ToBRFV. The technical solution of the present invention is as follows:

[0006] A mutant plasmid vector for preventing and controlling tomato brown wrinkled fruit virus, the mutant plasmid vector comprising a nucleotide sequence as shown in SEQ ID NO.1; the nucleotide sequence of mutant RNA2 in the mutant plasmid vector is shown in SEQ ID NO.2.

[0007] Further, the preparation method of the mutant plasmid vector is as follows:

[0008] (1) Intermediate vector pCB F Construction of R2-2bPT:

[0009] The intermediate vector of the mutant plasmid vector is pCB F R2-2bPT, intermediate vector pCB F R2-2bPT contains CMV Fny The full-length RNA2 sequence of the isolate, with TAATAG inserted between positions 2682 g and 2683 g, and SmaI restriction site; according to the CMV published in GenBank Fny RNA2 sequence (accession number: D00355), designed primers Fny2-2683-F and Fny2-2682-R; pCB301-CMV F ny-R2 was used as a template, and reverse PCR amplification was performed under the action of Phanta Max Super-Fidelity DNA Polymerase (Vazyme). After the plasmid template was degraded by DpnI (NEB), the PCR amplified fragment was digested with SmaI and self-ligated. The ligated product was transformed into Escherichia coli DH5α. The vector pCB was confirmed by colony PCR, plasmid digestion and DNA sequencing. F R2-2bPT; the sequence of the primer Fny2-2683-F is shown in SEQ ID NO.3, and the sequence of the primer Fny2-2682-R is shown in SEQ ID NO.4.

[0010] (2) Insert the intermediate vector pCB F R2-2bPT Sma I single enzyme digestion, obtain linear intermediate vector pCB F R2-2bPT was homologously recombined with the ToBRFV gene fragment with the nucleotide sequence of SEQ ID NO.1 using the kit pEASY®-Basic Seamless Cloning and Assembly Kit (TransGen) to obtain a mutant plasmid vector named pCB F R2-2bPT-ToBRFV 73-294 ; The sequence of the primer ToBRFV-73-F used in homologous recombination is shown in SEQ ID NO.5, and the sequence of the primer ToBRFV-294-R is shown in SEQ ID NO.6.

[0011] Furthermore, the present invention also includes the mutant plasmid vector pCB F R2-2bPT-ToBRFV 73-294 Application in the prevention and treatment of tomato brown wrinkled fruit virus; the application steps are as follows:

[0012] pCB F R2-2bPT-ToBRFV 73-294 Transform Agrobacterium with CMV Fny The plasmids of wild-type RNA1 and wild-type RNA3 of the isolates were mixed and pre-inoculated into tomatoes with Agrobacterium.

[0013] Beneficial effects of the present invention:

[0014] (1) For the obtained cucumber mosaic virus RNA2 2b protein premature termination mutant pCB F R2-2bPT, the present invention further inserts the ToBRFV conservative fragment after the new termination codon to obtain the 2b protein premature termination mutant of cucumber mosaic virus RNA2 containing the ToBRFV fragment. Fny Mixed inoculation of plasmids of the isolate's wild-type RNA1 and wild-type RNA3 can prevent infection by the virulent ToBRFV and can be used as a attenuated vaccine against tomato brown wrinkled fruit virus.

[0015] (2) After the plasmids were transformed into Agrobacterium, they were respectively Fny Agrobacterium containing wild-type RNA1 and wild-type RNA3 plasmids was mixed and pre-inoculated into plants. Plants pre-inoculated with the mutant had a preventive effect against ToBRFV.

[0016] The ToBRFV gene fragment inserted into the mutant plasmid provided by the present invention is a conservative sequence of the ToBRFV genome with a length of 222 bp, which has the potential to prevent and treat ToBRFV isolates. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 Schematic diagram of the vector, where (a) is the basic vector pCB301-CMV Fny -R2 schematic diagram, (b) is the intermediate vector pCB F Schematic diagram of R2-2bPT, (c) pCB containing the attenuated mutant of ToBRFV F R2-2bPT-ToBRFV 73-294 Schematic diagram; LB, left border of T-DNA region; RB, right border of T-DNA region; 35S, promoter (2x35S); RZ, ribozyme (HDV ribozyme); NOS, terminator (NOS terminator).

[0018] Figure 2 R1+R3+pCB F R2-2bPT-ToBRFV 73-294 3dRT-PCR detection inoculated on Nicotiana benthamiana; M is the D2000 molecular weight standard of Tiangen Company; R1 is CMV Fny RNA1; R3 is CMV Fny RNA3; pCB F R2-2bPT-ToBRFV 73-294 Contains CMV FnyThe full sequence of RNA2 was inserted into the 222 bp conservative sequence of ToBRFV after the premature termination codon of 2b protein; vaccine 1, vaccine 2, vaccine 3 and vaccine 4 were respectively vaccinated with R1+R3+pCB F R2-2bPT-ToBRFV 73-294 Four different treatments of Nicotiana benthamiana.

[0019] Figure 3 RT-PCR detection on Nicotiana benthamiana 3 days after friction inoculation with ToBRFV; M is the D2000 molecular weight standard of Tiangen Company; R1 is CMV Fny RNA1; R3 is CMV Fny RNA3; pCB F R2-2bPT-ToBRFV 73-294 Contains CMV Fny The full sequence of RNA2 was inserted into the 222 bp conservative sequence of ToBRFV after the premature termination codon of 2b protein; vaccine 1, vaccine 2, vaccine 3 and vaccine 4 were respectively vaccinated with R1+R3+pCB F R2-2bPT-ToBRFV 73-294 Four different treatments of Nicotiana benthamiana inoculated with ToBRFV; ToBRFV 1, ToBRFV 2, and ToBRFV 3, respectively, are three different treatments of Nicotiana benthamiana inoculated with ToBRFV.

[0020] Figure 4 pCB 8 days after friction inoculation with ToBRFV F R2-2bPT-ToBRFV 73-294 Causes weak symptoms in Nicotiana benthamiana; R1 is CMV Fny RNA1; R3 is CMV Fny RNA3; pCB F R2-2bPT-ToBRFV 73-294 Contains CMV Fny The full sequence of RNA2 was inserted into the 222 bp conservative sequence of ToBRFV after the premature termination codon of 2b protein; CK1, CK2, and CK3 were controls of Nicotiana benthamiana without any treatment; Vaccine 1, Vaccine 2, Vaccine 3, and Vaccine 4 were respectively vaccinated with R1+R3+pCB F R2-2bPT-ToBRFV 73-294 Four different treatments of Nicotiana benthamiana inoculated with ToBRFV; ToBRFV 1, ToBRFV 2, ToBRFV 3, three different treatments of Nicotiana benthamiana inoculated with ToBRFV.

[0021] Figure 5 R1+R3+pCBF R2-2bPT-ToBRFV 73-294 3dRT-PCR detection inoculated on tomatoes; M is the D2000 molecular weight standard of Tiangen Company; R1 is CMV Fny RNA1; R3 is CMV Fny RNA3; pCB F R2-2bPT-ToBRFV 73-294 Contains CMV Fny The full sequence of RNA2 was inserted into the 222 bp conservative sequence of ToBRFV after the premature termination codon of 2b protein; vaccine 1, vaccine 2 and vaccine 3 were respectively vaccinated with R1+R3+pCB F R2-2bPT-ToBRFV 73-294 Three different treatments of tomatoes.

[0022] Figure 6 RT-PCR detection on tomatoes 3 days after friction inoculation of ToBRFV; M is the D2000 molecular weight standard of Tiangen; R1 is CMV Fny RNA1; R3 is CMV Fny RNA3; pCB F R2-2bPT-ToBRFV 73-294 , containing CMV Fny The full sequence of RNA2 was inserted into the 222 bp conservative sequence of ToBRFV after the premature termination codon of 2b protein; vaccine 1, vaccine 2 and vaccine 3 were respectively vaccinated with R1+R3+pCB F R2-2bPT-ToBRFV 73-294 ToBRFV 1, ToBRFV 2 and ToBRFV 3 are three different treatments of tomatoes inoculated with ToBRFV.

[0023] Figure 7 The viral replication on tomatoes 3, 6, 9, and 12 days after friction inoculation with ToBRFV; vaccine treatment group, inoculated with R1+R3+pCB F R2-2bPT-ToBRFV 73-294 Tomatoes inoculated with ToBRFV; the strong toxin treatment groups, ToBRFV 1, ToBRFV 2 and ToBRFV3, are three different treatments of tomatoes inoculated with ToBRFV.

[0024] Figure 8The fluorescence quantitative curves on tomatoes after friction inoculation of ToBRFV; among them, (a) is the fluorescence quantitative curve three days after the strong attack of ToBRFV, (b) is the fluorescence quantitative curve six days after the strong attack of ToBRFV, (c) is the fluorescence quantitative curve nine days after the strong attack of ToBRFV, and (d) is the fluorescence quantitative curve twelve days after the strong attack of ToBRFV. DETAILED DESCRIPTION

[0025] The present invention is further described below in conjunction with specific embodiments to make the advantages and features of the present invention clearer. However, the embodiments are exemplary only and do not constitute any limitation to the scope of the present invention. It should be understood by those skilled in the art that the details and forms of the technical solution of the present invention may be modified or replaced without departing from the spirit and essence of the present invention, but these modifications and replacements all belong to the protection scope of the present invention.

[0026] The experimental materials used in the examples of the present invention that are not specifically described are all conventional experimental materials in the field and can be purchased through commercial channels. If the specific experimental conditions and methods are not specified in the examples of the present invention, conventional conditions are usually followed, such as J. Sambrook et al., ed., Molecular Cloning Experiment Guide (3rd Edition), Science Press, 2002; DL Spector et al., ed., Cell Experiment Guide, Science Press, 2001; or the conditions recommended by the manufacturer.

[0027] Example 1. pCB F R2-2bPT-ToBRFV 73-294 Build

[0028] Cloning of partial fragments of ToBRFV: Total RNA from tomatoes infected with ToBRFV (U23058.1) was extracted using TrlZol (Invitrogen), and reverse transcription was performed under the action of Reverse Transcriptase M-MLV (AG). The reverse primer was ToBRFV-RdRp-SamI-294R. The reaction conditions were: denaturation at 80°C for 3 min without adding enzymes; after adding reverse transcriptase, reaction was carried out at 42°C for 1.5 h. Then, the reverse transcription product cDNA was used as a template, and PCR reaction was carried out under the action of 2×Taq Master Mix (AG). The primer pair was ToBRFV-RdRp-SamI-73F and ToBRFV-RdRp-SamI-294R; PCR conditions: 95°C pre-denaturation for 3min; 95°C denaturation for 15s, 52°C annealing for 15s, 72°C extension for 12s, 30 cycles; 72°C extension for 5min; 4°C storage; PCR product was a 222 bp conservative sequence fragment in ToBRFV, and the nucleotide sequence was shown in SEQ ID NO.1. The PCR product was recovered by a DNA recovery kit and set aside.

[0029] According to the CMV published in GenBank Fny The sequence of RNA2 (accession number: D00355) was used to design primers Fny2-2683-F and Fny2-2682-R. Fny -R2 was used as a template, and reverse PCR amplification was performed under the action of Phanta Max Super-Fidelity DNA Polymerase (Vazyme). After the plasmid template was degraded by DpnI (NEB), the PCR amplified fragment was SmaI After restriction digestion, the ligation product was transformed into Escherichia coli DH5α. The vector pCB was confirmed by colony PCR, plasmid restriction digestion and DNA sequencing. F The sequence of the primer Fny2-2683-F is shown in SEQ ID NO.3, and the sequence of the primer Fny2-2682-R is shown in SEQ ID NO.4.

[0030] pCB F R2-2bPT Sma I single enzyme digestion, obtain linear intermediate vector pCB FR2-2bPT was homologously recombined with the ToBRFV gene fragment with the nucleotide sequence of SEQ ID NO.1 using the kit pEASY®-Basic Seamless Cloning and Assembly Kit (TransGen) to obtain a mutant plasmid vector named pCB F R2-2bPT-ToBRFV 73-294 ; The sequence of the primer ToBRFV-73-F used in homologous recombination is shown in SEQ ID NO.5, and the sequence of the primer ToBRFV-294-R is shown in SEQ ID NO.6; The schematic diagram of the construction is shown in Figure 1 shown.

[0031] Result analysis: After the ligation product was transformed, the product was initially screened by colony PCR and DNA sequencing, confirming that the plasmid contained the 222 bp gene sequence of ToBRFV.

[0032] Example 2. Plasmid vector pCB F R2-2bPT-ToBRFV 73-294 Biological effects

[0033] Agrobacterium infiltration and infection of Nicotiana benthamiana: First, wild-type CMV Fny RNA1, pCB F R2-2bPT-ToBRFV 73-294 , wild-type CMV Fny The plasmids of RNA3 were transformed into competent cells of Agrobacterium GV3101, respectively, and coated on LB plates with 50 µg / ml kanamycin and 100 µg / ml rifampicin. After culturing at 28°C for 48 h, a single plaque was picked for colony PCR verification, and then a single plaque was picked in 2 ml LB culture medium (50 µg / ml kanamycin, 100 µg / ml rifampicin) and cultured at 28°C, 222 rpm for 24 h.

[0034] Induction: Take CMV-containing Fny RNA1, pCB F R2-2bPT-ToBRFV 73-294 、CMV Fny RNA3, 100 µL of bacterial suspension was added to 5 ml of LB culture medium (containing 50 µg / ml kanamycin and 100 µg / ml rifampicin), and cultured at 28°C with shaking at 222 rpm until OD 600 is 0.5.

[0035] Resuspension: Place the induced bacterial solution in a 10 ml centrifuge tube and centrifuge at 6000 rpm for 10 min at room temperature; collect the bacterial cells and resuspend them in 1 ml Agrobacterium resuspension solution (10 mM MgCl2, 10 mM MES, 0.1 mM AS) and pipette to mix well. Take 50 ul of bacterial solution to 1 ml resuspension solution and measure its OD 600 The concentration was adjusted to obtain OD 600 The OD value of the remaining bacterial solution is 1.5, and the OD value of the remaining bacterial solution is adjusted according to the ratio of the bacterial solution and the resuspension solution. 600 The OD of the three bacterial cultures was 1.5. 600 Consistent.

[0036] Adjust the three OD 600 Value of bacterial solution (containing CMV Fny RNA1, pCB F R2-2bPT-ToBRFV 73-294 、CMV Fny RNA3) in equal proportions (i.e. R1+R3+pCB F R2-2bPT-ToBRFV 73-294 ), let it stand at 28℃ for 3 h to obtain the vaccine bacterial solution.

[0037] Inoculation: Take a 1 ml disposable syringe, remove the needle and absorb the Agrobacterium solution, select Nicotiana benthamiana and tomato plants with the same growth, and use pressure to inject the vaccine solution in the syringe between the veins on the back of the leaves. Inject two symmetrical leaves for each plant, and the injection amount of each leaf should cover at least 1 / 3 of the leaf. Inoculate the solution on 4 plants respectively to obtain four replicates of the vaccine.

[0038] The inoculated plants were cultured at 26 °C with alternating 16 h light / 8 h dark cycles.

[0039] Results: 7 days after vaccination, CMV Fny RNA1+RNA2-2bPT-ToBRFV 73-294 +RNA3 was basically the same as the healthy control, with no obvious symptoms of viral disease. F R2-2bPT-ToBRFV 73-294 It is a weak mutant.

[0040] To detect the genetic stability of the mutant after inoculation of tobacco, samples were taken from the uninoculated system leaves (the upper part of the inoculated leaves) 3 days after inoculation, and RT-PCR was used to detect whether the heterologous virus insertion fragment was stable. The primer information is: the sequence of CMV-1935-F is shown in SEQ ID NO.7, and the sequence of CMV-ToBRFV-240-R is shown in SEQ ID NO.8; the fragment size is 998bp.

[0041] like Figure 2 and Figure 5 As shown, the results of analysis: pCB F R2-2bPT-ToBRFV 73-294 On the third day after inoculation of Nicotiana benthamiana and tomato plants, the virus replication signal could be detected in the systemic leaves using RT-PCR. Based on the size of the amplified fragment, it could be determined that the inserted ToBRFV fragment still existed.

[0042] Example 3. Plasmid vector pCB F R2-2bPT-ToBRFV 73-294 Cross-protection effect test on Nicotiana benthamiana

[0043] Using the method in Example 2, wild-type CMV was inoculated Fny RNA1, pCB F R2-2bPT-ToBRFV 73-294 and wild-type CMV Fny Three days after inoculation with the attenuated mutant, the plants pre-inoculated with the attenuated mutant (vaccine 1, vaccine 2, vaccine 3, vaccine 4) and the plants not pre-inoculated with the attenuated mutant (ToBRFV1, ToBRFV2, ToBRFV3) were rubbed with juice containing ToBRFV diseased tomato plants to test their cross-protection effect.

[0044] like Figure 3 and Figure 4 As shown, the results were analyzed: RT-PCR detected the stable presence of ToBRFV 3 days after the plants (Vaccine 1, Vaccine 2, Vaccine 3, Vaccine 4) pre-inoculated with attenuated mutants and the plants (ToBRFV1, ToBRFV2, ToBRFV3) not pre-inoculated with attenuated mutants were rubbed with the juice of ToBRFV diseased tomato plants. The primer information is: the sequence of ToBRFV-F-1828 is shown in SEQ ID NO.9, and the sequence of ToBRFV-R-2288 is shown in SEQ ID NO.10; the fragment size is 460 bp. When ToBRFV was directly inoculated into Nicotiana benthamiana, the leaves showed curling, shrinking and wilting, and the plants were dwarfed until they died completely; pre-inoculated with wild-type CMV Fny RNA1, pCB F R2-2bPT-ToBRFV 73-294 and wild-type CMV Fny The RNA3 Nicotiana benthamiana was then inoculated with the target strong virus (ToBRFV). The plant height was slightly shorter than that of the healthy control, and the growth state was good, with only slight yellowing symptoms, indicating that the pre-inoculation with CMV Fny RNA1+RNA2-2bPT-ToBRFV73-294 +RNA3 Nicotiana benthamiana has a better cross-protection effect against ToBRFV.

[0045] Example 4. Plasmid vector pCB F R2-2bPT-ToBRFV 73-294 Cross-protection effect test on tomatoes

[0046] Using the method in Example 2, wild-type CMV was inoculated Fny RNA1, pCB F R2-2bPT-ToBRFV 73-294 and wild-type CMV Fny Three days after inoculation with the attenuated mutant, the plants pre-inoculated with the attenuated mutant (vaccine 1, vaccine 2, vaccine 3) and the plants not pre-inoculated with the attenuated mutant (ToBRFV1, ToBRFV2, ToBRFV3) were rubbed with juice containing diseased tomato plants of ToBRFV to test their cross-protection effect.

[0047] like Figure 5 and Figure 6 As shown, the results of analysis: pCB F R2-2bPT-ToBRFV 73-294 On the third day after inoculation of tomato plants, the virus replication signal could be detected in the systemic leaves using RT-PCR, and based on the size of the amplified fragment, it could be determined that the inserted ToBRFV fragment still existed.

[0048] ToBRFV was directly inoculated into tomato plants. Since the symptoms of ToBRFV on tomato leaves were not obvious, Realtime PCR was used to quantitatively monitor the replication of the virus in tomatoes that were inoculated with ToBRFV and ToBRFV alone. A nucleotide sequence on the polymerase was selected to design Realtime PCR primers. The primer sequence information is as follows: the sequence of ToBRFV-2148-F is shown in SEQ ID NO.11, and the sequence of ToBRFV-2288-R is shown in SEQ ID NO.12. The internal reference primer information is as follows: the sequence of Act-F is shown in SEQ ID NO.13, and the sequence of Act-R is shown in SEQ ID NO.14. The total RNA of tomato leaves was extracted using RNA Easy FastPlant Tissue Kit (TIANGEN), reverse transcribed into cDNA using HiScript Ⅲ RT SuperMix for QPCR (Vazyme), and Realtime PCR was performed using 2×Realtime PCR Super mix (Polymer) fluorescent dye. The real-time PCR data were analyzed using the 2(-ΔΔCt) method, and the graphs were drawn using GraphPad Prism 8.0.2.263 software.

[0049] like Figure 7 and Figure 8 As shown, the ToBRFV was inoculated on tomatoes, and the results showed that the virus replication continued to increase with the extension of the inoculation time; Fny RNA1+RNA2-2bPT-ToBRFV 73-294 The tomato plants with +RNA3 were inoculated with the target strong virus (ToBRFV). The plants grew well. Fluorescence quantitative PCR showed that the virus replication was the same as that of the internal reference gene, with no significant growth trend, indicating that the pre-inoculation of CMV Fny RNA1+RNA2-2bPT-ToBRFV 73-294 Tomatoes with +RNA3 have better cross-protection against ToBRFV.

[0050] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. A mutant plasmid vector for preventing and controlling tomato brown wrinkled fruit virus, characterized in that: The mutant plasmid vector contains the nucleotide sequence shown in SEQ ID NO.1; the nucleotide sequence of the mutant RNA2 in the mutant plasmid vector is shown in SEQ ID NO.2; The preparation method of the mutant plasmid vector comprises the following steps: (1) Intermediate vector pCB F Construction of R2-2bPT: The intermediate vector of the mutant plasmid vector is pCB F R2-2bPT, intermediate vector pCB F R2-2bPT contains CMV Fny The full-length RNA2 sequence of the isolate, with TAATAG inserted between positions 2682 g and 2683 g, and Sma I restriction site; (2) Insert the intermediate vector pCB F R2-2bPT Sma I single enzyme digestion, obtain linear intermediate vector pCB F R2-2bPT, linear intermediate vector pCB F R2-2bPT was homologously recombined with the ToBRFV gene fragment with the nucleotide sequence of SEQ ID NO.1 to obtain a mutant plasmid vector named pCB F R2-2bPT-ToBRFV 73-294 ; The intermediate vector pCB in step (1) F In the preparation of R2-2bPT, pCB301-CMV Fny -R2 is used as a template, and the primers used are: Fny2-2683-F with a sequence as shown in SEQ ID NO.3 and Fny2-2682-R with a sequence as shown in SEQ ID NO.4; the primers used for homologous recombination in step (2) are ToBRFV-73-F with a sequence as shown in SEQ ID NO.5 and ToBRFV-294-R with a sequence as shown in SEQ ID NO.

6.

2. The mutant plasmid vector pCB as claimed in claim 1 F R2-2bPT-ToBRFV 73-294 Application in constructing attenuated vaccine against tomato brown wrinkled fruit virus.

3. The mutant plasmid vector pCB as claimed in claim 1 F R2-2bPT-ToBRFV 73-294 Application in the prevention and control of tomato brown wrinkled fruit virus.

4. The use according to claim 3, characterized in that: The steps of the application are as follows: pCB F R2-2bPT-ToBRFV 73-294 Transform Agrobacterium with CMV Fny The plasmids of wild-type RNA1 and wild-type RNA3 of the isolates were mixed with Agrobacterium and pre-inoculated on tomato.